138 related articles for article (PubMed ID: 29526307)
1. Effectiveness in the treatment of solar urticaria with omalizumab: Report of 7 cases.
Sahuquillo-Torralba A; Rodríguez-Serna M; Botella Estrada R
Med Clin (Barc); 2018 Dec; 151(11):460-461. PubMed ID: 29526307
[No Abstract] [Full Text] [Related]
2. Effectiveness of omalizumab in severe solar urticaria.
de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
[No Abstract] [Full Text] [Related]
3. Solar urticaria treated with omalizumab.
Schaffenburg WC; Guerrero KT; Marks SN
Cutis; 2019 Jul; 104(1):E4-E5. PubMed ID: 31487346
[No Abstract] [Full Text] [Related]
4. Incapacitating solar urticaria: successful treatment with omalizumab.
Kieselova K; Santiago F; Henrique M
An Bras Dermatol; 2019 Jul; 94(3):331-333. PubMed ID: 31365663
[TBL] [Abstract][Full Text] [Related]
5. Response to Omalizumab in Solar Urticaria: Report of 3 Cases.
Rodríguez-Jiménez P; Chicharro P; Pérez-Plaza A; de Argila D
Actas Dermosifiliogr; 2017 Oct; 108(8):e53-e55. PubMed ID: 28457471
[TBL] [Abstract][Full Text] [Related]
6. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria.
Arasi S; Crisafulli G; Caminiti L; Guarneri F; Aversa T; Porcaro F; Pajno GB
Pediatr Allergy Immunol; 2015 Sep; 26(6):583-5. PubMed ID: 26033828
[No Abstract] [Full Text] [Related]
7. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest.
Combalia A; Fernández-Sartorio C; Aguilera P
Actas Dermosifiliogr; 2017; 108(6):593-594. PubMed ID: 28168968
[No Abstract] [Full Text] [Related]
8. Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.
Aubin F; Avenel-Audran M; Jeanmougin M; Adamski H; Peyron JL; Marguery MC; Léonard F; Puyraveau M; Viguier M;
J Am Acad Dermatol; 2016 Mar; 74(3):574-5. PubMed ID: 26892659
[No Abstract] [Full Text] [Related]
9. Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.
Levi A; Tal Y; Dranitzki Z; Shalit M; Enk CD
Pediatr Allergy Immunol; 2015 Sep; 26(6):588-90. PubMed ID: 26172942
[No Abstract] [Full Text] [Related]
10. Solar urticaria induced by visible light: successful treatment with omalizumab.
Terrani I; Bircher AJ; Scherer Hofmeier K
Clin Exp Dermatol; 2016 Dec; 41(8):890-892. PubMed ID: 27766671
[TBL] [Abstract][Full Text] [Related]
11. Solar urticaria caused by visible light in a 33-year-old male refractory to treatment with omalizumab.
Wright E; Kurland E; Lim HW
Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):316-317. PubMed ID: 32141097
[No Abstract] [Full Text] [Related]
12. Evaluating patient responses to omalizumab in solar urticaria.
Griffin LL; Haylett AK; Rhodes LE
Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):57-65. PubMed ID: 30338865
[No Abstract] [Full Text] [Related]
13. Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature.
Snast I; Kremer N; Lapidoth M; Enk CD; Tal Y; Rosman Y; Confino-Cohen R; Hodak E; Levi A
J Allergy Clin Immunol Pract; 2018; 6(4):1198-1204.e3. PubMed ID: 29572192
[TBL] [Abstract][Full Text] [Related]
14. [Partial response of solar urticaria to omalizumab therapy].
Kowalzick L; Thiel W; C Bielfeld ; Ziegler H; Eickenscheidt L
Hautarzt; 2017 Jun; 68(6):492-496. PubMed ID: 27995273
[TBL] [Abstract][Full Text] [Related]
15. Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature.
Morgado-Carrasco D; Fustà-Novell X; Podlipnik S; Combalia A; Aguilera P
Photodermatol Photoimmunol Photomed; 2018 May; 34(3):194-199. PubMed ID: 29171925
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab in the Treatment of Chronic Inducible Urticaria.
Chicharro P; Rodríguez P; de Argila D
Actas Dermosifiliogr; 2017 Jun; 108(5):423-431. PubMed ID: 27717421
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial.
Metz M; Schütz A; Weller K; Gorczyza M; Zimmer S; Staubach P; Merk HF; Maurer M
J Allergy Clin Immunol; 2017 Sep; 140(3):864-867.e5. PubMed ID: 28389393
[No Abstract] [Full Text] [Related]
18. Transient Pruritic Erythema as a Forme Fruste of Solar Urticaria.
Azrielant S; Khanimov I; Sprecher E; Ellenbogen E
Isr Med Assoc J; 2020 Apr; 22(4):227-231. PubMed ID: 32286025
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
Geller M
Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
[No Abstract] [Full Text] [Related]
20. Partial improvement of solar urticaria after omalizumab.
Waibel KH; Reese DA; Hamilton RG; Devillez RL
J Allergy Clin Immunol; 2010 Feb; 125(2):490-1. PubMed ID: 20159260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
